Cargando…
Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source
IMPORTANCE: Oral β-lactam antibiotics are traditionally not recommended to treat Enterobacterales bacteremia because of concerns over subtherapeutic serum concentrations, but there is a lack of outcomes data, specifically after initial treatment with parenteral antibiotics. Given the limited data an...
Autores principales: | Sutton, Jesse D., Stevens, Vanessa W., Chang, Nai-Chung N., Khader, Karim, Timbrook, Tristan T., Spivak, Emily S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545306/ https://www.ncbi.nlm.nih.gov/pubmed/33030555 http://dx.doi.org/10.1001/jamanetworkopen.2020.20166 |
Ejemplares similares
-
848. Low-Bioavailability vs. High-Bioavailability Oral Antibiotics for the Definitive Treatment of Enterobacteriaceae Bacteremia from Suspected Urine Source in Hospitalized Veterans
por: Sutton, Jesse D, et al.
Publicado: (2019) -
Oral Fluoroquinolone or Trimethoprim-Sulfamethoxazole vs ß-Lactams as Step-Down Therapy for Enterobacteriaceae Bacteremia: Systematic Review and Meta-analysis
por: Punjabi, Chitra, et al.
Publicado: (2019) -
Outcomes of high-dose oral beta-lactam definitive therapy compared to fluoroquinolone or trimethoprim-sulfamethoxazole oral therapy for bacteremia secondary to a urinary tract infection
por: Geyer, Abigail C., et al.
Publicado: (2023) -
271. Clinical Outcomes Treating Gram-Negative Bacteremia with Oral Beta-Lactams vs. Trimethoprim-Sulfamethoxazole or Fluoroquinolone Step-Down Therapy
por: Sinclair, Emily, et al.
Publicado: (2020) -
210. Step-down from IV to oral therapy in patients with bacteremia due to Enterobacteriaceae: fluoroquinolones (FQ) vs. ß-lactams (BL) or trimethoprim-sulfamethoxazole (TMP-SMX)
por: Meng, Lina, et al.
Publicado: (2019)